Dr Amna Sheri is a Consultant Medical Oncologist based in London. She manages all aspects of systemic therapy for early and advanced breast cancer including adjuvant therapy, neo-adjuvant therapy, immunotherapy, treatment of secondary breast cancer, novel biological and targeted therapies and breast cancer in young women.
Dr Sheri graduated from Imperial College London in 2004 and trained in Medical Oncology at the Royal Marsden Hospital. Following this, she was awarded an MD research degree from the Institute of Cancer Research for her work into the prediction of outcome following neo-adjvuant therapy. In 2015, she appointed as a Consultant Medical Oncologist specialising in Breast Cancer and Melanoma at the Royal Free Hospital.
Dr Sheri is actively involved in research particularly on the use of prognostic and predictive biomarkers in early breast cancer. She has published extensively in peer-reviewed journals and presented her work at both national and international meetings.